Columbia Care Sees Consensus Price Target Rise To $14.70

On August 12, Columbia Care Inc. (CSE: CCHW) reported its second-quarter financial results, wherein the company announced record revenues of $109.7 million, up 19% sequentially, with a gross margin of 43%. Gross profits rose 23.6% to $43.3 million, while Adjusted EBITDA came in at $16.4%, up 58% sequentially, and an EBITDA margin of 15%. The company reaffirmed its full year 2021 guidance of $500-$530 million in revenue and an Adjusted EBITDA of $95-$105 million.

Analysts made a few changes to their 12-month price target, raising the average consensus to $14.70 from $13.77 before the earnings. Columbia Care has 12 analysts covering the stock with 4 having strong buy ratings, 7 have buy ratings and a single analyst has a hold rating. The street high sits at $19 while the lowest comes in at $12.

Canaccord reiterated their buy rating and $15 price target on Columbia Care, saying that the company reported solid top-line growth and the company remains its top pick in their cannabis coverage.

Cambria Gold Mines — sponsored Sponsored · Cambria Gold Mines

Columbia Care generally came in line with Canaccord estimates, barely missing their revenue and Adjusted EBITDA expectations. Canaccord says that the revenue growth was boosted by a partial inclusion of Greem Leaf Medical. While Columbia Care reported California, Colorado, Massachusetts, Ohio, and Pennsylvania as its top 5 markets, Canaccord says its other operations in the states of Flordia, Arizona (+23), New Jersey (+20%), and Illinois (+15%) saw great growth.

Columbia Care saw its dispensary count increase to 77 retail locations with further locations in various stages of completion. The company also is adding to its Colorado exposure by acquiring Medicine Man for $42 million.

Below you can see Canaccord’s updated 2021 and 2022 estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Questcorp Begins 600 Metre Phase 2B Drill Program at La Union

Selkirk Copper Wraps 54,579 Metre Phase 2 Program at Minto, Hits 5.97% Copper Equivalent

Related News

Village Farms: Analysts Expect Q3 Revenues To Hit US$68.7 Million

Village Farms International (TSX: VFF) announced that they will be reporting their third quarter financials...

Monday, November 8, 2021, 05:17:00 PM

Dollarama: BMO Expects Boost In Second Half Of 2021 Due To Reopenings

Dollarama Inc (TSX: DOL) reported its first-quarter financials on June 9th. Dollarama reported revenues of...

Thursday, June 10, 2021, 03:52:00 PM

Canaccord Raises Trulieve Price Target To $75 From $60

The last two weeks have been quite an enjoyable time for U.S cannabis sector investors....

Wednesday, January 13, 2021, 02:53:00 PM

Curaleaf Consensus Target Remains Flat After Record Quarter

On August 9, Curaleaf Holdings (CSE: CURA) reported record second quarter financial results. The company...

Tuesday, August 17, 2021, 11:43:00 AM

Tilray: Ladenburg Thalmann Remains Neutral Following Q3 Results

Monday night Tilray Inc (NASDAQ: TLRY) reported its third quarter results. Revenue for the quarter...

Wednesday, November 11, 2020, 02:07:00 PM